Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, L. L.
Right arrow Articles by Horrocks, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, L. L.
Right arrow Articles by Horrocks, L. A.
NEUROLOGY 1986;36:1200
© 1986 American Academy of Neurology

Dietary essential fatty acids, vitamin E, and Charcot-Marie-Tooth disease

Lowell L. Williams, Margaret M. O'Dougherty, Francis S. Wright, Rosalind J. Bobulski and Lloyd A. Horrocks

Departments of Pediatrics and Physiological Chemistry and the Children's Hospital Research Foundation, Ohio State University, Columbus, OH.

Twenty patients with type I Charcot-Marie-Tooth disease received dietary supplementation with the essential fatty acids (EFA), linoleic and gamma-linolenic acids, and vitamin E. A 3-month blinded trial of placebo (paraffin oil and vitamin E, 81.6 IU/d) was followed by 1 year of 3 grams daily of EFA and vitamin E. Serum fatty acid values doubled, but total esterified fatty acid proportions did not change. Arachidonic acid proportions correlated with the amount of prostaglandin-mediated lymphocyte suppression measured at the same times. Improvement demonstrated at the end of the placebo period by neuropsychological tests and neurologic examination was maintained during the 1 year of EFA supplementation. This effect may reflect a membrane stabilization benefit of vitamin E.

Address correspondence and reprint requests to Dr. Williams, 214 Ross Hall, Children's Hospital, Columbus, OH 43205.

Supported by grants from the Muscular Dystrophy Association and EFAMOL Inc.

Accepted for publication December 27, 1985.




This article has been cited by other articles:


Home page
J Hand Surg Eur VolHome page
V. E. WOOD, D. HUENE, and J. NGUYEN
Treatment of the Upper Limb in Charcot-Marie-Tooth Disease
J Hand Surg Eur Vol., August 1, 1995; 20(4): 511 - 518.
[Abstract] [PDF]


Home page
J Hand Surg Eur VolHome page
M. J. MILLER, L. L. WILLIAMS, S. L. SLACK, and J. F. NAPPI
The Hand in Charcot-Marie-Tooth Disease
J Hand Surg Eur Vol., April 1, 1991; 16(2): 191 - 196.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by AAN Enterprises, Inc.